Healthpeak Properties, Inc. (NYSE:DOC) Shares Sold by Gulf International Bank UK Ltd

Gulf International Bank UK Ltd lowered its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 55.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,290 shares of the real estate investment trust’s stock after selling 40,713 shares during the quarter. Gulf International Bank UK Ltd’s holdings in Healthpeak Properties were worth $652,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in DOC. TCTC Holdings LLC raised its holdings in shares of Healthpeak Properties by 124.3% during the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 751 shares during the last quarter. Future Financial Wealth Managment LLC purchased a new stake in shares of Healthpeak Properties in the first quarter valued at approximately $30,000. S.A. Mason LLC grew its position in shares of Healthpeak Properties by 160.9% in the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust’s stock valued at $30,000 after purchasing an additional 925 shares in the last quarter. Dagco Inc. purchased a new stake in shares of Healthpeak Properties in the first quarter valued at approximately $30,000. Finally, GKV Capital Management Co. Inc. purchased a new stake in shares of Healthpeak Properties in the first quarter valued at approximately $36,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Insider Buying and Selling at Healthpeak Properties

In other news, CEO Scott M. Brinker purchased 2,930 shares of the stock in a transaction dated Thursday, July 31st. The stock was acquired at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the transaction, the chief executive officer directly owned 210,416 shares in the company, valued at approximately $3,589,696.96. This represents a 1.41% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Tommy G. Thompson purchased 5,777 shares of the stock in a transaction dated Wednesday, May 28th. The shares were purchased at an average price of $17.27 per share, with a total value of $99,768.79. Following the completion of the transaction, the director owned 144,290 shares of the company’s stock, valued at approximately $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 14,560 shares of company stock valued at $249,898. Company insiders own 0.23% of the company’s stock.

Analyst Upgrades and Downgrades

DOC has been the subject of a number of analyst reports. Robert W. Baird set a $21.00 price target on Healthpeak Properties and gave the company an “outperform” rating in a research report on Wednesday, July 30th. Evercore ISI dropped their price target on Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating for the company in a research report on Monday, April 28th. Wells Fargo & Company dropped their price target on Healthpeak Properties from $22.00 to $20.00 and set an “equal weight” rating for the company in a research report on Monday, June 2nd. Scotiabank lowered Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and dropped their price target for the company from $21.00 to $19.00 in a research report on Tuesday, July 29th. Finally, Wedbush cut their target price on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a research note on Monday, April 28th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, Healthpeak Properties currently has an average rating of “Moderate Buy” and an average target price of $23.00.

Healthpeak Properties Price Performance

DOC stock opened at $17.32 on Friday. The business has a fifty day moving average of $17.64 and a two-hundred day moving average of $18.48. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. The stock has a market cap of $12.04 billion, a price-to-earnings ratio of 72.17, a price-to-earnings-growth ratio of 2.21 and a beta of 1.05. Healthpeak Properties, Inc. has a 52-week low of $16.63 and a 52-week high of $23.26.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%. The business had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. During the same period last year, the business posted $0.45 earnings per share. The company’s quarterly revenue was down .2% on a year-over-year basis. As a group, research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The company also recently declared a dividend, which will be paid on Friday, August 29th. Stockholders of record on Tuesday, August 19th will be given a dividend of $0.1017 per share. This represents a dividend yield of 705.0%. The ex-dividend date is Monday, August 18th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 508.33%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.